Latest news
SystImmune Announces First Patient Dosed in Global Phase 3 Trial of BL-M14D1 in First-Line Extensive-Stage Small Cell Lung Cancer - PR NewswirePR Newswire · Wed, 05 Aug 2026 12:00:00 GMTMerck advances sac-TMT into first-line lung cancer redesign after endometrial Phase III win - AllSciAllSci · Wed, 05 Aug 2026 09:44:57 GMTJazz to withdraw Zepzelca with FDA in second-line small cell lung cancer - Fierce PharmaFierce Pharma · Tue, 04 Aug 2026 13:18:16 GMTMolecular Testing Turnaround Before First-Line Therapy in Advanced NSCLC - OncodailyOncodaily · Fri, 31 Jul 2026 17:37:27 GMT